FY2025 · ended Dec 31, 2025 · Revenue $5.10M, +24.2% YoY · Filed May 14, 2026
Regenerative Medical Technology Group Inc. (RMTG) files with the SEC under industry code 5990, Retail-Retail Stores, NEC. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $5.1 million and a net loss of $7.8 million. Free cash flow was -$1.3 million. As of Jun 30, 2026 it held $1.3 million in cash and investments and $650,106 in total debt.
Revenue (TTM)
$9.41M
+94.3% vs year-ago TTM
Net income (TTM)
$-8.82M
-136.7% vs year-ago TTM
Operating cash flow (TTM)
$268,563
+141.2% vs year-ago TTM
Free cash flow (TTM)
$-582,331
-466.3% vs year-ago TTM
EPS (TTM)
$-0.68
-129.4% vs year-ago TTM
Dividend per share
None
Shares outstanding
13.14M
+4.8% vs prior year
Net cash
$673,198
as of Jun 30, 2026
Operating margin
0.5%
FY 2026
Company profile
- Industry
- Retail-Retail Stores, NEC (SIC 5990)
- Listed as
- RMTG (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Boca Raton, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1760026
- Former names
- MESO NUMISMATICS, INC. (until Oct 24, 2024)
Other Retail-Retail Stores, NEC companies
- JD.com, Inc. JD
- Ulta Beauty, Inc. ULTA
- Bath & Body Works, Inc. BBWI
- Sally Beauty Holdings, Inc. SBH
- ATRenew Inc. RERE
- Petco Health & Wellness Company, Inc. WOOF
- Titan Machinery Inc. TITN
- Star Group, L.P. SGU
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $5.1M | $4.1M | $2.4M | $1.5M | $437,887 |
| Operating income | -$867,162 | $81,181 | — | — | — |
| Net income | -$7.8M | -$5.6M | -$9.8M | -$5.5M | -$12.9M |
| Diluted EPS | -$0.62 | -$0.44 | -$0.79 | -$0.45 | — |
| Operating cash flow | -$706,519 | $850,699 | -$419,199 | -$1.1M | -$9.9M |
| Free cash flow | -$1.3M | $635,280 | -$804,795 | -$1.3M | — |
| Total assets | $4.5M | $3.8M | $2.9M | $8.1M | $9.3M |
| Total liabilities | $39.2M | $31.2M | $24.7M | $20.1M | $16.1M |
| Stockholders' equity | -$34.7M | -$27.4M | -$21.8M | -$12.0M | -$6.8M |
| Cash and investments | $956,718 | — | $530,540 | — | $3.0M |
| Total debt | $629,083 | $275,256 | $2,714 | $33,963 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Aug 25, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 19, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Jun 9, 2026 | Mar 31, 2026 |
| 10-K | Annual report | May 14, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 19, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 19, 2025 | Jun 30, 2025 |
All 101 Regenerative Medical Technology Group Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.